UNION CITY, Calif.,
May 27, 2014 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company
manufacturing point-of-care blood analysis systems, announced today
that Clint Severson, chairman and
chief executive officer, will present at the Jefferies 2014 Global
Healthcare Conference on Monday, June 2,
2014 at 3:00 p.m. ET. The
conference will be held at the Grand Hyatt in New York City.
About Abaxis
Abaxis develops, manufactures, markets and sells portable blood
analysis systems for use in any veterinary or human patient-care
setting to provide clinicians with rapid blood constituent
measurements. The system consists of a compact, 5.1 kilogram (11.2
pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs that contain all the chemicals required
to perform a panel of up to 13 tests on veterinary patients and 14
tests on human patients. The system can be operated with minimal
training and performs multiple routine tests on whole blood, serum
or plasma samples. The system provides test results in less than 12
minutes with the precision and accuracy equivalent to a clinical
laboratory analyzer. The veterinary business also provides to the
animal health and research market a line of hematology instruments
for point-of-care complete blood counts (CBC), a specialty
instrument to screen for and detect clotting disorders and to
measure equine fibrinogen levels, a handheld instrument for the
rapid assessment of certain critical care tests and rapid
point-of-care tests for Heartworm infections, Parvovirus, Giardia
and Lyme disease. Abaxis, through its AVRL division, provides
routine laboratory testing as well as specialty testing for
veterinarians nationwide. For more information, visit
http://www.abaxis.com.
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
ABAXIS,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
SOURCE Abaxis, Inc.